Dr. Doug Melton and colleagues at the Harvard Stem Cell Institute recently announced new partnerships with Novartis and AstraZeneca to advance stem cell research for...

$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?

Plus, a guide to choosing between the six pumps available!

Complete with a savings card, a patient coaching program, and more!

Lilly announced that the FDA has approved its Humalog 200 units/mL KwikPen (insulin lispro) for type 1 and type 2 diabetes, making it the first concentrated mealtime...

Major A1c improvements, weight loss, and no injections!

Will it be the first US city to have warning labels for sugary drinks?

Three things to know about the new US Surgeon General Dr. Vivek Murthy, who has his sights set on tackling obesity.

First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?

How a dramatic 23% increase in new diabetes cases impacts people living with diabetes nationwide.

diaTribe was excited to learn that Novo Nordisk has extended its partnership with the professional cycling Team Novo Nordisk (TNN) for an additional two years. Founded...

A better patient experience, brand new devices, and a louder patient voice!

Plus, the latest on the new Bluetooth Share Receiver and the Tandem t:slim G4.

Starting in 2012, the American Diabetes Association established the Pathway to Stop Diabetes initiative, a $1.6 million grant (paid over five years) to support the...

What happens when these two unique drugs are taken together?

Plus, a new consumer version launches for $59/year.

We'd love to get your feedback on our new website design!

How will a new drug fare in a 4,000-patient, four-year study?

The company’s ambitious goal to reach 20 million patients by 2020.

Our interview with Manny. Plus, a 2-way cellular-enabled touchscreen glucose meter, unlimited strips, and contextual diabetes coaching for a competitive monthly fee?